AtriCure's CEO Discusses Q2 2012 Results - Earnings Call Transcript

AtriCure, Inc. (ATRC)

Q2 2012 Results Earnings Call

August 2, 2012 4:30 PM ET


David Drachman – President and CEO

Mike Hooven – Co-founder

Dick Johnston – Chairman

Lynn Pieper – IR Consultant


Brooks West – Piper Jaffray

Jason Mills – Canaccord Genuity

Danielle Antalffy – Leerink Swann

Matt Dolan – Roth Capital Partners

Charley Jones – Barrington Research

Larry Haimovitch – HMTC



Good morning and welcome to AtriCure's Second Quarter 2012 Earnings Conference Call. My name is Fab and I will be your coordinator for the call today. At this time, all participants are in listen-only mode. We will be facilitating a question-and-answer session toward the end of today's call. As a reminder, this call is being recorded for replay purposes.

I would now like to turn the call over to Mr. David Drachman, President and Chief Executive Officer of AtriCure. Mr. Drachman, please proceed.

David Drachman

Thank you, Fab. Good morning, and welcome to our second quarter earnings conference call. Joining me on the call today, two members of our Board of Directors, our co-founder Mr. Mike Hooven, and our Chairman Mr. Dick Johnston, as well as Lynn Pieper our Investor Relations Consultant.

I would now like to turn the call over to Lynn, for a few introductory comments.

Lynn Pieper

Thank you, Dave. By now you should have received a copy of the earnings press release. If you've not received a copy, please call 513-755-4136, to have one emailed to you.

If you liked this article you might like

These 5 Stocks Are Poised for Breakouts

AtriCure Suffers From Weak Chart, Downgrade

AtriCure Suffers From Weak Chart, Downgrade

5 Breakout Stocks to Buy Off Weakness

Today's Weak On High Volume Stock: AtriCure (ATRC)

AtriCure (ATRC) Weak On High Volume Today